Leem J W, Gwak Y S, Lee E H, Chung S S, Kim Y S, Nam T S
Department of Physiology, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Med J. 2001 Feb;42(1):74-83. doi: 10.3349/ymj.2001.42.1.74.
Spontaneous pain, allodynia and hyperalgesia are well known phenomena following peripheral nerve or tissue injury, and it is speculated that secondary hyperalgesia and allodynia, are generally thought to depend on a hyperexcitability (sensitization) of neurons in the dorsal horn. It is supposed that the sensitization may be due to various actions of neurotransmitters (SP, CGRP, excitatory amino acids) released from the primary afferent fibers. In this study, we examined effects of the iontophoretically applied SP and CGRP on the response to EAA receptor agonists (NMDA and non-NMDA) in the WDR dorsal horn neurones and see if the effects of SP or CGRP mimic the characteristic response pattern known in various pain models. The main results are summarized as follows: 1) SP specifically potentiated NMDA response. 2) CGRP non-specifically potentiated both NMDA and AMPA responses. Potentiation of NMDA response, however, was significantly greater than that of AMPA response. 3) 50% of SP applied cells and 15.8% of CGRP applied cells showed reciprocal changes(potentiation of NMDA response and suppression of AMPA response). These results are generally consistent with the sensitization characteristics in diverse pain models and suggests that the modulatory effects of SP and CGRP on NMDA and non-NMDA (AMPA) response are, at least in part, contribute to the development of sensitization in various pain models.
自发痛、痛觉过敏和异常性疼痛是周围神经或组织损伤后常见的现象,据推测,继发性痛觉过敏和异常性疼痛通常被认为依赖于背角神经元的兴奋性过高(致敏)。据推测,这种致敏可能是由于初级传入纤维释放的神经递质(P物质、降钙素基因相关肽、兴奋性氨基酸)的各种作用所致。在本研究中,我们研究了离子导入施加的P物质和降钙素基因相关肽对广动力范围背角神经元对兴奋性氨基酸受体激动剂(N-甲基-D-天冬氨酸和非N-甲基-D-天冬氨酸)反应的影响,并观察P物质或降钙素基因相关肽的作用是否模拟了各种疼痛模型中已知的特征性反应模式。主要结果总结如下:1)P物质特异性增强N-甲基-D-天冬氨酸反应。2)降钙素基因相关肽非特异性地增强N-甲基-D-天冬氨酸和α-氨基-3-羟基-5-甲基-4-异恶唑丙酸反应。然而,N-甲基-D-天冬氨酸反应的增强明显大于α-氨基-3-羟基-5-甲基-4-异恶唑丙酸反应。3)50%施加P物质的细胞和15.8%施加降钙素基因相关肽的细胞表现出相反的变化(N-甲基-D-天冬氨酸反应增强和α-氨基-3-羟基-5-甲基-4-异恶唑丙酸反应抑制)。这些结果总体上与各种疼痛模型中的致敏特征一致,并表明P物质和降钙素基因相关肽对N-甲基-D-天冬氨酸和非N-甲基-D-天冬氨酸(α-氨基-3-羟基-5-甲基-4-异恶唑丙酸)反应的调节作用至少部分促成了各种疼痛模型中致敏的发展。